D-dimer rise in outpatients with COVID 19 and comorbidities
Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases...
Enregistré dans:
Auteur principal: | Miljković Ana R. |
---|---|
Format: | article |
Langue: | EN SR |
Publié: |
Serbian Medical Society, Belgrade
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b64e7e57dc664c6cbde2f3ebf63d26c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evaluation of Prognosis and Risk of Death by Neutrophil/Lymphocyte Ratio, C-Reactive Protein/Albumin Ratio and Plasma D-Dimer in Patients with Pulmonary Thromboembolism
par: Shan T, et autres
Publié: (2021) -
Biochemical role of serum ferratin and d-dimer parameters in COVID 19 diagnosis
par: Abdullah Farasani
Publié: (2021) -
Characteristics and treatment of coagulopathy associated with COVID-19
par: Miljić Predrag
Publié: (2021) -
Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis
par: Antonella Tufano, et autres
Publié: (2021) -
Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients
par: Ma Hui, et autres
Publié: (2021)